Healthcare News | Medical Research

Innate Immunity Has a Role in Vitiligo Pathogenesis

Innate immunity may play a role in susceptibility to vitiligo, a new study showed.

Rasha Turky Abdel-Razek Abdel-Aziz, of Minia University, Minia, Egypt, and colleagues recently published the results of a cross-sectional comparative study that showed a significant difference in the distribution of the Toll-like receptor (TLR)9 rs187084 between patients with vitiligo and those without.

Risk-Reducing Surgery Linked to Survival in Young BRCA Carriers

Eva Blondeaux, MDGenetics & Breast Cancer | May 20, 2025

Risk-reducing surgery improves survival in young BRCA1/2 carriers, study shows, guiding counseling for high-risk patients.

A New, Viable Approach in Hemophilia: Inhibition of Activated Protein C

Andrew MorenoHemophilia | May 20, 2025

A preclinical mouse study showed hemostasis restoration, as well as use for active bleeding and internal bleeding prevention.

COVID-19’s Impact on Biopsy Rates, IgAN Diagnoses Within the European Union

Katie KoskoIgA Nephropathy | May 20, 2025

A study found low rates of IgAN in the EU, but lower biopsy rates during the COVID-19 pandemic may have delayed diagnoses.

Successful HIV Viral Suppression With At-Home Administration

Jordana JampelHIV | May 20, 2025

At-home administration was safe, effective, and had higher participant satisfaction.

New Data on Terlipressin Presented at DDW 2025

Peter Richardson, BMedSci, BM, BS, MRCPAcute Kidney Injury | May 20, 2025

Drs. Peter Richardson and George Wan of Mallinckrodt Pharmaceuticals discussed new data on terlipressin for HRS-AKI.

Kidney Organizations Join Forces to Develop Framework for Glomerular Disease Centers of Excellence

Charlotte RobinsonIgA Nephropathy | May 20, 2025

Three kidney organizations will develop a consensus framework for Centers of Excellence in Glomerular Disease Care.

Targeted-Release Budesonide Shows Benefit for Patients With Severe Renal Impairment

Katie KoskoIgA Nephropathy | May 19, 2025

Nefecon can safely be used to treat severe renal impairment and lowers proteinuria in patients with IgAN.

Phase 2 Data Support a Safer Immunotherapy Option for PNH

Andrew MorenoPNH | May 19, 2025

A novel complement-targeting agent shows impressive efficacy and safety without immunosuppression of the classical pathway.

DocWire Content Partners

CardioNerds

Gain insights from The CardioNerds, a group of cardiology experts who aim to democratize cardiovascular education.

The Fellow on Call

Fundamentals, core concepts, and important management approaches in the field of hematology and oncology

Healthcare Unfiltered

Dr. Chadi Nabhan, a renowned voice in hematology and oncology, tackles a multitude of relevant health care topics.

The Oncology Brothers

Drs. Rohit Gosain and Rahul Gosain discuss practice-changing data and standards of oncology care.

Practice Tips With Dr. Lichaa

Dr. Hady Lichaa is an interventional cardiologist specializing in complex coronary interventions.

Rheumatology Rounds With Dr. Maheswaranathan

Review important issues in the rheumatology space, including lupus, rheumatoid arthritis, and more, from Dr. Maheswaranathan.

Powered by DocWire News

GI Oncology Now is the leading medical news resource for practicing oncologists and healthcare providers treating gastrointestinal malignancies, offering the latest study data and research breakthroughs related to colorectal, gastric, liver, pancreatic, and esophageal cancers.

Heme Today produces the latest news and research for hematologists and oncologists focused on blood disorders such as clotting, red and white blood cell, and iron disorders, including conference highlights, late-breaking research, interviews with leaders in the field, and more.

A medical news property for practicing oncologists treating lung malignancies, Lung Cancers Today features breaking news, commentary, expert interviews, and data analysis to inform providers on the latest research and most effective clinical practices in the lung cancers space.

Nephrology Times delivers the latest news in nephrological treatments and technologies, curating content from clinical trials, conference highlights, and perspectives from key opinion leaders, with the goal of better informing care decisions and improving patient outcomes.

The Latest From GI Oncology Now

Suvemcitug Combination Shows Promise in MSS/pMMR Colorectal Cancer

Emily MenendezColorectal Cancer | March 17, 2025

Suvemcitug, envafolimab, and FOLFIRI may serve as a new second-line treatment option for cold tumors.

Genetic Resistance to KRASG12C Inhibitors in CRC and PDAC

Emily MenendezPancreatic Cancer | March 17, 2025

KRASG12C inhibitors can have reduced efficacy in patients with alterations in KRAS, EGFR, and other genes.

Complete Response to Immunotherapy in HCC: Insights From IMbrave150

Emily MenendezLiver Cancer | March 14, 2025

Complete responders with HCC have prolonged survival and durable disease control even after therapy has been discontinued.

177Lu-edotreotide Improves PFS, OS Over Everolimus for SSTR-Positive GEP-NETs

Emily MenendezGEP-NETs | March 12, 2025

The primary objective of median PFS was significantly longer for patients treated with 177Lu-edotreotide.

MATTERHORN: Durvalumab Plus FLOT Improves EFS and pCR in Gastric, GEJ Cancers

Emily MenendezGastroesophageal Cancer | March 12, 2025

The safety profile of the combination was consistent with known profiles, and no new safety findings were observed.

Risk for Choledocholithiasis Higher in Older Adult Patients With Cholangiocarcinoma

Emily MenendezBile Duct Cancer | March 11, 2025

Older patients in their 70s with extrahepatic CCA have a higher rate of choledocholithiasis.

The Latest From Heme Today

A New, Viable Approach in Hemophilia: Inhibition of Activated Protein C

Andrew MorenoHemophilia | May 20, 2025

A preclinical mouse study showed hemostasis restoration, as well as use for active bleeding and internal bleeding prevention.

Phase 2 Data Support a Safer Immunotherapy Option for PNH

Andrew MorenoPNH | May 19, 2025

A novel complement-targeting agent shows impressive efficacy and safety without immunosuppression of the classical pathway.

Is Plasma Mannose-Binding Lectin a Clue to Higher VTE Risk?

Andrew MorenoVTE | May 16, 2025

Investigation of a HUNT Study cohort found elevated plasma MBL levels to be associated with increased risk for future VTE.

Study Data Bolster Quercetin Treatment of Fanconi Anemia in Young Persons

Andrew MorenoAnemia | May 16, 2025

Reactive oxygen species levels decreased and patients with evident bone marrow failure showed hematological response.

Extending Anticoagulation is Reasonable in Children with VTE, Data Suggest

Andrew MorenoVTE | May 19, 2025

A cohort study of extended-phase anticoagulation following acute management was performed in the phase III EINSTEIN Jr trial.

Hemophilia B Gene Therapy Shows Promise as Long-Term Treatment

Melissa BadamoHemophilia | May 13, 2025

Fidanacogene elaparvovec gene therapy is a safe and effective treatment for patients with hemophilia B, research shows.

Expert Interviews

Network Websites

GU Oncology Now delivers the latest news in genitourinary oncology therapeutics, clinical trials, conference coverage, and research data, highlighting important advancements in treatments and technologies to better inform providers' decisions and improve patient outcomes.

Blood Cancers Today provides hematologists and oncologists with news, education, and research relevant to their patients and practices. Featuring the latest clinical updates from all facets of the specialty, it offers insights and exclusive interviews from experts in the field.

Cancer Nursing Today delivers critical news, research, and commentary to support oncology nurses throughout their education and careers. Its goal is to advance oncology treatments and care practices and promote the nurse’s role in enhanced patient outcomes and quality of life.

MashupMD is an innovative medical news and social media aggregator. The platform is optimized to deliver rapid access to the latest headlines in healthcare and collections of key medical content based on what healthcare professionals around the world are reading and sharing.

Urban Health Today is the leading independent news source that provides urban healthcare professionals with relevant research and policy developments that impact patients and their practices. Its coverage focuses on clinical, social, and environmental health disparities.